![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Kent Imaging and SerenaGroup Team Up to Improve Wound Tissue Assessment
Kent Imaging and SerenaGroup Team Up to Improve Wound Tissue Assessment
Kent Imaging and SerenaGroup announced a strategic partnership to develop techniques to assess tissue in wounds using one of Kent Imaging’s devices.
The device, the KD203, uses near infrared imaging technology to perform non-invasive to capture diagnostics about oxygenated blood availability in tissue.
The device measures oxygen saturation, relative oxyhemoglobin levels and relative deoxyhemoglobin levels in superficial tissue, using color-coded images to provide critical information about the tissue.
Upcoming Events
-
18Jul
-
21Oct